[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588620":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":13,"collaborators":7,"id":17,"slug":18,"hasResults":19,"nctId":20,"briefTitle":21,"officialTitle":22,"acronym":7,"eligibilityCriteria":23,"healthyVolunteers":24,"sex":25,"minAge":26,"maxAge":7,"enrollmentInfo":27,"targetDuration":7,"studyType":30,"phases":7,"briefSummary":31,"conditions":32,"keywords":7,"overallStatus":34,"whyStopped":7,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":7},{"fullName":5,"class":6},"Fudan University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","fecal methylation site-based testing and fecal Helicobacter pylori gastric cancer susceptibility gene-based testing","To establish an early diagnostic test system for gastric cancer based on the methylation site detection technology in feces, with or without the combination of Helicobacter pylori gastric cancer susceptibility gene detection, and then to evaluate the clinical diagnostic value of this test system.",{"type":14,"investigatorFullName":15,"investigatorTitle":16,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Dazhi Xu","Director of the gastric surgery department","100588620","fecal-dna-methylation-and-helicobacter-pylori-gastric-cancer-susceptibility-genes-test-100588620",false,"NCT06943768","Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test","Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer","Inclusion Criteria:\n\n* Age ≥ 18 years old, male or female not limited.\n* Within 90 days, the gastroscopy and\u002For pathological results confirm the absence of gastric cancer.\n* Patients must be able to fully understand the informed consent form and be able to personally sign it.\n\nExclusion Criteria:\n\n* Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders.\n* A previous history of malignant tumors of the upper gastrointestinal tract.\n* Women during pregnancy.\n* Those with undefined pathology.\n* Those with unsatisfactory sample retention (e.g., too small a sample size)",true,"ALL","18 Years",{"count":28,"type":29},9654,"ESTIMATED","OBSERVATIONAL","This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the \"gold standard\" imaging tests, CT, gastroscopy and\u002For pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.",[33],"Gastric (Stomach) Cancer","NOT_YET_RECRUITING","2025-06-21",{"date":37,"type":38},"2025-06-24","ACTUAL",{"date":40,"type":29},"2025-12-01",{"date":42,"type":29},"2026-06-30",{"name":5,"class":6}]